NORML Formally Responds to DEA’s Proposed Changes to Marijuana Cultivation Rules

NORML

As a result, the DEA has been encouraged for over a decade to expand the pool of federally licensed cannabis producers — a move that the agency has largely resisted. To date, however, the DEA has failed to either affirm or reject any of the more than 30 applications it has received.

DEA 200

DEA Report: Fewer Marijuana Seizures, But More Arrests In 2018

NORML

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Statistical Report, the agency and its law enforcement partners confiscated an estimated 2.82 LAW ENFORCEMENT assets DEA eradication legalization seizures

DEA 214

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

NORML Says DEA’s Newly Proposed Bulk Cultivation Rules Are “Unduly Onerous, Expensive, and Impractical”

NORML

The DEA now estimates that, under the new rules, it may approve between three and 15 total applicants. In 2016, the DEA publicly announced that it would, for the first time, begin accepting applications from private entities wishing to grow research-grade cannabis.

DEA 152

Why Dr. Sue Sisley Sued the DEA for Stonewalling Cannabis Research

NORML

We also spoke with her attorneys, who explained why they believed the DEA broke the law by holding up long-promised medical marijuana research licenses. It’s been nearly three years since the DEA announced its revolutionary cultivator program.

DEA 277

DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action

NORML

The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.

DEA 221

Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators

NORML

Justices for the US Court of Appeals for the District of Columbia denied the petition following a filing by DEA in the Federal Register stating that the agency “intends to promulgate regulations” to review several dozen federal cultivation applications.

DEA 198

DEA Says It Will Finally Let Others Grow Research-Grade Cannabis

Leafly

Two days before a federal court deadline, the DEA says it will do what it said it would do three years ago. The post DEA Says It Will Finally Let Others Grow Research-Grade Cannabis appeared first on Leafly. Politics DEA research

DEA 114

Court: DEA Must Explain Its Failure to Act Upon Pending Marijuana Cultivation Applications

NORML

” To date, however, the agency has neither affirmed or denied any of the 26 applicants that have sought the DEA’s permission for a federal cultivation license. “[This filing is] asking the court for an order compelling the DEA to process our application.

Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis?

Leafly

The post Wasn’t the DEA Going to Let Others Grow Research-Grade Cannabis? Science & Tech DEA nida researchYes, it was. So why has the agency delayed applications? Sue Sisley demands an answer, and the courts agree with her.

DEA 110

DEA loosens rules on prescription CBD drug Epidiolex

Leafly

The post DEA loosens rules on prescription CBD drug Epidiolex appeared first on Leafly. Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year. Health Politics cannabidiol cbd Epidiolex GW Pharma GW Pharmaceuticals

DEA 61

CVS Ignores DEA, Says It’s Already Selling CBD Products

Leafly

The post CVS Ignores DEA, Says It’s Already Selling CBD Products appeared first on Leafly. Industry Politics cannabidiol cbd DEA FDAThe nation's largest drugstore chain is selling CBD products in 8 states. Meanwhile, independent CBD stores are being raided by police in Texas.

DEA 88

Scientists Sue DEA as it Drags its Feet and Hampers Cannabis Research

WeedAdvisor

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. Here, DEA can act with little expenditure of resources.”.

DEA 114

DEA Publishes Notice of Proposed Rulemaking On Marijuana Research

Cannabis Law Report

Cannabis research in the USA has been held back by the DEA’s stance on the issue, although it has been increasing the amount of cannabis it wants produced for research over the last couple of years. The DEA says the proposed rule will see additional registered growers and more diverse variety of marijuana strains available for research. Currently, the DEA has 37 pending applications to grow marijuana for research.

DEA 58

DEA Finally Agrees to Expand Marijuana Research Amid Pressure from Lawsuit

WeedAdvisor

Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. This likely would have been longer, but the DEA had not anticipated a legal threat to force some action.

DEA 70

DEA releases 2019 National Drug Threat Assessment

Cannabis Law Report

WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced the publication of the 2019 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. Press Release.

DEA 56

USDA NON-ENFORCEMENT OF DEA-LAB AND DISPOSAL REQUIREMENTS

Cannabis Law Report

After a significant outcry by the hemp community, the USDA is backing down from its requirement that all hemp be tested at DEA-registered labs for the 2020 season. BY ALICIA ALTENAU, GREEN LIGHT LAW GROUP —.

DEA 56

Press Release: DEA proposes process to expand marijuana research in the United States

Cannabis Law Report

The Drug Enforcement Administration continues to support additional research into marijuana and its components, and we believe registering more growers will advance the scientific and medical research already being conducted,” said DEA Acting Administrator Dhillon. “DEA

DEA 65

From DEA to Legal Cannabis: Charles Feldmann Weighs In

CannaTech

As a Marine Corps federal prosecutor, DEA Drug Task Force Commander and state narcotics prosecutor, Charles spent many years engaged in the War on Drugs. A Former DEA Prosecutor’s Journey into the Global Cannabis Industry.

DEA 87

DEA To Grow 3,200,000 Grams Of Research Cannabis In 2020

Cannabis Law Report

The Drug Enforcement Administration (DEA) finalized its plans to authorize the cultivation of 3,200,000 grams of marijuana for research purposes next year—a 30 percent increase from 2019’s quota. DEA Finalizes Plan To Grow 3.2

DEA 56

Cannabis Litigation: Second Circuit Could Force DEA to Re- or Deschedule Marijuana

Canna Law Blog

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. The DEA has routinely denied each petition, or declined to accept it outright.

DEA 111

DEA removes cannabis drug Epidiolex from controlled substances list

SMPL

The DEA’s announcement lowers physician barriers to prescribing Epidiolex because they won’t have to notify the agency when prescribing it. The expansion comes two years after the DEA first took Epidiolex off the most-restrictive class of controlled substances. That decision, issued months after the FDA approved the drug for treating certain types of epilepsy, was the first time the DEA removed any type of cannabis from Schedule 1.

DEA 40

Cannabis Researcher Plans To Sue DEA Over Substandard Research Cannabis

Cannabis Law Report

The Marijuana Time introduce their article by writing… A cannabis researcher at Arizona’s Scottsdale Research Institute plans to sue the Drug Enforcement Administration (DEA) over what she is saying is low-grade cannabis that is unacceptable for testing.

DEA 72

Green Light Law Group: DEA ANNOUNCEMENT MARKS END OF ERA

Cannabis Law Report

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 56

U.S. Federal Court Tells DEA to Evaluate Rescheduling Cannabis, in Light of its Medical Benefits

WeedAdvisor

The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis. The court’s sense of urgency finally puts judicial pressure on the DEA. The DEA is now forced to face the issue.

DEA 50

Greg Ibach, undersecretary for the U.S. Department of Agriculture says the departnent will drop federal DEA testing rules for 2020

Cannabis Law Report

DEA will still expect states to work with their laboratories to try to achieve certification for the 2021 crop year,” he added. “We USDA drops DEA hemp testing requirement for 2020, while FDA acknowledges demand for CBD. Hemp Industry Daily report.

USA Dept of Justice Press Release: DEA Announces Steps Necessary to Improve Access to Marijuana Research

Cannabis Law Report

DEA Announces Steps Necessary to Improve Access to Marijuana Research. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. Following. The Press Release in full. Department of Justice.

DEA 69

DEA Does Not Have The Resources To Test For Hemp Vs Cannabis Says Article

Cannabis Law Report

The report reveals … ndustry members worry the limitation could delay THC testing and create bottlenecks, especially in remote areas far from a DEA-registered lab. “It This is a departure for the DEA, which does not require labs to be accredited to handle narcotics.

DEA 56

FDA, DEA Seize 44 Websites Selling Illicit THC Vaping Cartridges

Cannabis Law Report

The U.S. Food and Drug Administration and the Drug Enforcement Administration seized forty-four websites offering to sell illicit vaping cartridges containing tetrahydrocannabinol (THC), the primary psychoactive component of the cannabis plant.

DEA 56

MJ Biz: Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status

Cannabis Law Report

Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1. Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status.

DEA 69

According To DEA Data Do You Know Which State Grows The Most Illegal Cannabis ?

Cannabis Law Report

You might think it’s California,but actually it is …… According to recently published DEA data about illegal grows it is Kentucky, where both recreational and medical marijuana are still illegal. The DEA confiscated over 1.8

DEA 56

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. The post The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

DEA 65

DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington’s Disease Drug Development

Cannabis Law Report

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada.

Constitutionality of Cannabis: Federal Lawsuit Against DEA, DOJ Proceeds

Marijuana Lawyer Blog

Defendants are acting-Attorney General Matthew Whitaker, the acting director of the DEA and the federal government. Additional Resources: Appeal Hearing in Cannabis Lawsuit Against the DEA , Dec. A federal lawsuit against the U.S. Drug Enforcement Administration and the U.S.

DEA 52

DEA Testing Requirement for Hemp Removed by USDA

The Joint Blog

According to the Daily, the testing delay comes after farmers and states alike complained there wouldn’t be enough DEA labs to handle demand. DEA will still expect states to work with their laboratories to try to achieve certification for the 2021 crop year,” he added.

DEA 26

US Federal Court Rejects Scottsdale Research Institute (SRI) Lawsuit Vs DEA

Cannabis Law Report

A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers. Marijuana Moment reports.

DEA 56